ResMed Inc (STU:RME)
€ 232.3 -1.9 (-0.81%) Market Cap: 34.52 Bil Enterprise Value: 34.92 Bil PE Ratio: 32.70 PB Ratio: 6.98 GF Score: 98/100

Resmed Inc at William Blair Growth Stock Conference Transcript

Jun 08, 2022 / 02:20PM GMT
Release Date Price: €198.62 (+1.86%)
Malgorzata Maria Kaczor Andrew
William Blair & Company L.L.C., Research Division - Partner

Good morning, everyone. Welcome again to day 3 of the William Blair Growth Stock Conference. Really appreciate everyone being here.

For those of you that don't know me, my name is Margaret Kaczor. I am the research analyst here at William Blair & Company who covers ResMed. I am required to inform you that you can obtain a complete list of research disclosures or potential conflicts of interest at williamblair.com.

Now we're very pleased to have Rob Douglas, President and COO and Interim Head now of Sleep and Respiratory Care Business; as well as Dave Pendarvis, Chief Administrative Officer and Global General Counsel, with us today.

Again, I offer a couple of sentences maybe before throwing it over to Rob, but it's been a very eventful few years for the sleep apnea market. Frankly, beginning with what seemed like an acceleration going into COVID, then COVID happened and then there's a huge demand for ventilatory support products. And then one of your competitors left the market

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot